PMID: 38806Jan 1, 1978

Follow-up treatment of schizophrenic psychoses: advantages and disadvantages of long-term medication

Arzneimittel-Forschung
H SteuberP Müller

Abstract

In completely remitted schizophrenic patients with formerly paranoid-hallucinatory symptoms, the reoccurrence of relapses can be reduced in an extremely high percentage by relatively low neuroleptic long-term treatment specifically adjusted to each patient. Without medication there is an extremely high rate of relapses to be expected. In prophylactic neuroleptic medication the dose must be calculated individually. The depressive syndrome, which can be observed in higher therapeutic dosages, will then be less frequent. The social handicap due to side-effects of prophylactic treatment is more tolerable than the risk of relapse. The follow-up records of the patients treated with long-term medication of the active drug show that, in spite of side-effects, occupational resocialisation and personal stabilisation could be established more easily than in the placebo group. By close psycho-social after-care a high percentage of relapses can be handled in out-patients.

Related Concepts

Antipsychotic Effect
Schizophrenia
Depressive Disorder
Postabortion
Lyogen
Clinical Trials
Relapse
Placebos
Double-Blind Method

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.